Global sacral nerve stimulation market

Global sacral nerve stimulation market size is expected to reach US$ 634.1 Mn by 2030, from US$ 422.7 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 6% during the forecast period.

Sacral nerve stimulation (SNS) is a minimally invasive procedure that involves placing a small medical device called an implantable neurostimulator to treat bladder, bowel, and pelvic floor disorders.

Global Sacral Nerve Stimulation Market - Regional Insights

• North America is expected to be the largest market for sacral nerve stimulation during the forecast period, accounting for over 35.7% of the market share in 2023. North America has established itself as the dominant regional market for sacral nerve stimulation. This is due to strong healthcare infrastructure and expenditure in countries like the U.S.
• Asia Pacific market is expected to be the second-largest market for sacral nerve stimulation market, accounting for over 25.2% of the market share in 2023. The Asia Pacific region has emerged as the fastest expanding sacral nerve stimulation market globally. Countries like China, India, Japan, and South Korea have growing healthcare needs of their large and rapidly developing populations.
• Europe market is expected to be the fastest-growing market for sacral nerve stimulation market, with a share of 19% during the forecast period. The growth of the market in Europe is due to the increasing prevalence of fecal incontinence in the region.

Figure 1. Global Sacral Nerve Stimulation Market Share (%), By Region, 2023

Analyst View: The sacral nerve stimulation market is anticipated to grow due to several factors, such as; increasing prevalence of urinary incontinence,  related pelvic floor disorders, and growing geriatric population, which is more prone to such conditions. Moreover, increasing clinical development by the market players for the development of innovative solutions is expected to propel the market growth over the forecast period.

Global Sacral Nerve Stimulation Market - Drivers

• Rising geriatric population: Increasing geriatric population globally is expected to propel the market growth over the forecast period. For instance, on October 1, 2022, according to the data published by the World Health Organization, in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Moreover, between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%.
• Growing prevalence of urinary incontinence: Increasing prevalence of urinary incontinence globally will aid in the market growth over the forecast period. For instance, in December 21, 2018, according to the data published by the National Center for Biotechnology Information (NCBI) between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%.

Global Sacral Nerve Stimulation Market - Opportunities

• Development of new stimulation systems: Development of new stimulation systems can unlock tremendous opportunities in the global sacral nerve stimulation market. With advancements in neuro technology, researchers are working on minimally invasive and targeted stimulation methods that can more effectively treat underlying medical conditions in a safe, affordable manner. Some of the new approaches being explored include wireless stimulation implants, micro-scale electrodes, and customized stimulation paradigms modulated by AI/ML algorithms.

Global Sacral Nerve Stimulation Market - Trends

• Wireless and battery less sacral nerve stimulation systems: The advent of wireless and battery less sacral nerve stimulation systems is expected to witness significant impact the global sacral nerve stimulation market in the near future. Sacral nerve stimulation is commonly used to treat overactive bladder, urinary retention, and fecal incontinence. The traditional systems require battery replacements every few years which involves additional surgeries. This increases the costs burden and risk to patients over the long run of treatment. For instance, on May 21, 2018, StimGuard, a medical device firm, secured the European CE-Mark for its battery-free, wireless neuromodulation device that is designed to stimulate the sacral nerve to address overactive bladder.

Global Sacral Nerve Stimulation Market - Restraints

• High cost of sacral nerve stimulation devices: The high cost of sacral nerve stimulation devices is posing significant challenges for the growth of the global sacral nerve stimulation market. Sacral nerve stimulation therapy involves implantation of a medical device which helps in the stimulation of sacral nerves to provide relief from conditions like overactive bladder, urinary incontinence, and fecal incontinence. However, the devices and surgical procedures that are required for sacral nerve stimulation are extremely expensive. For instance, according to the data published by the National Center for Biotechnology Information (NCBI), the therapy the cost of the sacral nerve stimulation surgical implant is US$ 22,970.

Counterbalance: The cost of the sacral nerve stimulation needs to be made affordable by the key market players, so that it becomes affordable among the general masses.

Figure 2. Global Sacral Nerve Stimulation Market Share (%), By Product Type, 2023

Global Sacral Nerve Stimulation Market - Recent Developments

Product and Technology Launch

• In February 22, 2022, Medtronic plc, a global in healthcare technology company, announced that it received approval from the U.S. Food and Drug Administration (FDA) for InterStim X ― the next generation of the InterStim portfolio's recharge-free device – and it is available immediately. Moreover, InterStim systems are the standard of care in advanced therapy options, and the most personalized system, to deliver sacral neuromodulation (SNM) therapy.
• In January 31, 2023, Axonics, Inc. a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced that the U.S. Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation system.

Business Development Activities by the Market Players

In April 2023, Axonics, Inc.,a global medical technology company that develops and commercialize novel products for the treatment of bladder and bowel dysfunction, announced the acquisition of a lead placement solution from Radian, LLC. that complements Axonics Inc.s’ existing sacral neuromodulation (SNM) offering.

Top Companies in Global Sacral Nerve Stimulation Market

• Medtronic plc.
• Boston Scientific Corporation
• Nevro Corp
• StimWave Technologies Inc.
• Axonics, Inc.
• Synapse Biomedical
• Uroplasty
• Jude Medical
• Cogentix Medical
• Others

Definition: Sacral nerve stimulation (SNS) is a minimally invasive procedure that involves placing a small medical device called an implantable neurostimulator to treat bladder, bowel, and pelvic floor disorders.

Detailed Segmentation:

• Global Sacral Nerve Stimulation Market, By Product Type
  • Implantable SNS Devices
  • External SNS Devices
  • Accessories
• Global Sacral Nerve Stimulation Market, By Application
  • Urinary and Fecal Incontinence
  • Chronic Pain
  • Others
• Global Sacral Nerve Stimulation Market, By End User
  • Hospital
  • Clinics
  • Ambulatory Surgery Centers
• Global Sacral Nerve Stimulation Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa